Trans Genic GroupTRANS GENIC GROUP INC.2342東証スタンダードサービス業FY ending Mar 2026, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|---|
| Drug discovery support business | -8.8%5y | 4,75737.3% | 2,2470.9% | 2,312-6.0% | 1,890-25.8% | 2,253-7.3% |
| Investments and Consulting business | +8.7%4y | 7,8193.5% | 9,1811.8% | 10,7714.0% | 11,1153.9% | 10,9214.4% |
| E-commerce business | — | 4,6993.3% | — | — | — | — |
| Others | — | 3,1203.7% | — | — | — | — |
| TGBS Business | — | 7,8193.5% | — | — | — | — |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第28期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第27期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第26期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第25期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第24期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第23期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 51 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.